Monitoring of Kidney Fibrosis Changes in Patients with Chronic Heart Failure
Keywords:
cardio renal syndrome, chronic kidney disease, chronic heart failure, glomerular filtration rate
Abstract
Accession of chronic kidney disease in patients with chronic heart failure worsens the course and prognosis of the disease. And the main reason for the loss of kidney function is the changes in the proximal tubules and the associated tubulointerstitial fibrosis, which requires early diagnosis and adequate therapy.
References
1. Atroshenko Ye. S. Patient with chronic heart failure and preserved systolic function of the left ventricle / Ye. S. Atroshenko // Heart failure '. - 2007. - T. 8. - 6. - P. 297-300
2. Adizova D.R. Ibroximova D. B., Adizova S. R. Adherence to treatment for chronic heart failure // Biology and Integrative Medicine. - 2020. - № 6 (46) .- p. 112-122
3. Adizova D.R. ECG features in the elderly and the elderly diagnosed with chronic heart failure // A new day in medicine. –2020. - №4 (33). – P. 39-41
4. Gadaev A.G., Xalilova F.A., Elmuradov F.X., Tosheva X.B. Structural and functional changes in the kidneys and heart in patients with XSN. Therapy Bulletin of Uzbekistan. 2018. -1 - S. 100-104.
5. K.F. Abdujalolovna. Assessment of Intracardiac Hemodynamics and Electrolyte Balance in Various Hemodynamic Types of Chronic Heart Failure Accompanied By Anemia // European Multidisciplinary Journal of Modern Science 7,63-71, 2022
6. Tosheva Khakima Bekmurodovna, Erkinova Nigora Erkinovna, Gadaev Abdigaffar Gadaevich, Djuraeva Nozima Oripovna, Khalilova Feruza Abdujalolovna (2020) Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study). Journal of Cardiovascular Disease Research, 11 (2), 59-65.
7. Tosheva Kh., Xalilova F., Gadaev A, Erkinova N., Djuraeva N. Impact Of Chronic Heart Failure On Comorbidities In Hot Climates On The Quality Of Life And Clinical Condition Of Patients. European Journal of Molecular & Clinical Medicine. ISSN 2515-8260 Volume 07, Issue 10, 2020.
8. Khalilova F. et al. COMORBIDE CASES IN CARDIORENAL SYNDROME AND ITS IMPACT ON PATIENTS'QUALITY OF LIFE //InterConf. – 2020.
9. Khalilova F. A. et al. COMORBIDE CASES IN CARDIORENAL SYNDROME AND ITS IMPACT ON PATIENTS'QUALITY OF LIFE //EDITOR COORDINATOR. – 2020. – С. 741.
10. Aslonova I. J. et al. The prevalence of chronic pyelonephritis in women with disturbed tolerance for glucose //Asian Journal of Multidimensional Research (AJMR). – 2019. – Т. 8. – №. 11. – С. 81-85.
11. Aslonova I. Z., Erkinova N. E., Tosheva K. B. The prevalence of chronic pyelonephritis in women with disturbed tolerance for glucose //International Journal of Pharmaceutical Research. – 2019. – Т. 11. – №. 4. – С. 866-868.
12. Тошева Х., Кайимова Д. И. Метаболик синдромнинг ривожланишида ирсиятнинг ахамияти //Биология и интегративная медицина. – 2017. – Т. 1. – С. 132.
13. Клычева М. А. и др. Роль психологии семейного воспитания в формировании поведенческих реакций у подростков //Наука молодых–Eruditio Juvenium. – 2015. – №. 2. – С. 75-79.
14. Bekmurodovna T. K., Chorievich Z. A. Study of frequency indicators of comorbid states at different functional classes of heart failure //ACADEMICIA: An International Multidisciplinary Research Journal. – 2021. – Т. 11. – №. 3. – С. 2556-2560.
15. Bekmurodovna T. K. et al. Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study) //Journal of Cardiovascular Disease Research. – 2020. – Т. 11. – №. 2. – С. 59-65.
16. Bekmurodovna T. K., Gadaevich G. A. Dynamics of Renal Fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia. – 2021.
17. Khaidarovich K. U., Bekmurodovna T. H., Abduzhalilovna K. F. Studying The Frequency Of The Symptoms Of Gastroesophageal Reflux Disease //JournalNX. – С. 48-52.
18. Тошева Х. Б., Кенжаева З. О. Пропаганда здорового образа жизни в селе как механизм сохранения здоровья сельского населения. – 2014.
19. Тошева Х., Кайимова Д. И. Role of heritable factors in development of the metabolic syndrome //Биология и интегративная медицина. – 2017. – №. 1. – С. 132-146.
20. Гадаев А. Г. и др. Роль некоторых маркеров в оценке течения Хронического кардиоренального синдрома. – 2018.
21. Нурбаев Ф. Э., Тошева Х. Б. Скрининг Сердечно-Сосудистых Заболеваний У Спортсменов //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – С. 8-9.
22. Тошева Х., Хазратов У., Нарзиев Ш. РОЛИ ДИСФУНКЦИИ ПОЧЕК В РАЗВИТИИ КОМОРБИДНОСТИ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ //Журнал вестник врача. – 2020. – Т. 1. – №. 3. – С. 93-96.
23. Khotamova R. S. Frequency of Comorbid Conditions in Chronic Heart Failure //Middle European Scientific Bulletin. – 2022. – Т. 24. – С. 260-264.
24. Khotamova R.S. The Role of Folk Medicine in the Treatment of Patients with Cardiovascular Diseases // Central Asian Journal of Medical and Natural Science (ISSN:2660-4159) Oct. 14, 2021. Page: 280-283.
25. Marenzi G., Lauri G., Guazzi M. et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis // Am J Med Sci. 2001. Vol. 321 (6). P. 359–366.
26. Nohria A., Hasselblad V., Stebbins A. etal.Cardiorenal interactions: insights from the ESCAPE trial // J Am Coll Cardiol. 2008. Vol. 51 (13). P. 1268–1274.
27. Prkacin I., Ozvald I., Cavrić G., Balenović D.,Bulum T., Flegar Mestrić Z. Importance of urinary NGAL, serum creatinine standardization and estimated glomerular filtration rate in resistant hypertension // Coll. Antropol. – 2013. – Vol. 37, №3. – Р. 7821–7825.
28. Ronco C., Haapio M., House A.A. et al. Cardiorenal syndrome // J Am Coll Cardiol. 2008Vol. 52 (19). P. 1527–1539.
29. Ruilope L.M., Segura J., Campo C., Rodicio J.L. Renal participation in cardiovascular risk in essential hypertension // Expert Rev Cardiovasc. Ther. 2003. Vol. 1 (2). P. 309–315.
30. Ronco C. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong / C. Ronco, A.A. House, M. Haapio // Intensive Care Med. – 2008. – Vol. 34. – P. 957–962.
31. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) // N Engl J Med. 1988. Vol. 319 (17). P. 1127–1134.
32. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure // N Engl J Med. 1999. Vol. 341 (8). P. 577–585.
33. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) // N Engl J Med. 1988. Vol. 319 (16). P. 1065–1072.
34. Silverberg D.S., Wexler D., Blum M. et al. The interaction between heart failure, renal failure and anemia – the cardio-renal anemia syndrome // Blood Purif. 2004. Vol. 22 (3). P. 277–284.
35. Waring W.S., Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of chronic kidney injury // Clin. Toxicol. – 2011
36. Yamamoto T., Noble N.A., Cohen A.H. et al.Expression of transforming growth factor β isoforms in human glomerular diseases // Kidney Int. – 1996. – Vol. 49. – Р. 461–469.
2. Adizova D.R. Ibroximova D. B., Adizova S. R. Adherence to treatment for chronic heart failure // Biology and Integrative Medicine. - 2020. - № 6 (46) .- p. 112-122
3. Adizova D.R. ECG features in the elderly and the elderly diagnosed with chronic heart failure // A new day in medicine. –2020. - №4 (33). – P. 39-41
4. Gadaev A.G., Xalilova F.A., Elmuradov F.X., Tosheva X.B. Structural and functional changes in the kidneys and heart in patients with XSN. Therapy Bulletin of Uzbekistan. 2018. -1 - S. 100-104.
5. K.F. Abdujalolovna. Assessment of Intracardiac Hemodynamics and Electrolyte Balance in Various Hemodynamic Types of Chronic Heart Failure Accompanied By Anemia // European Multidisciplinary Journal of Modern Science 7,63-71, 2022
6. Tosheva Khakima Bekmurodovna, Erkinova Nigora Erkinovna, Gadaev Abdigaffar Gadaevich, Djuraeva Nozima Oripovna, Khalilova Feruza Abdujalolovna (2020) Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study). Journal of Cardiovascular Disease Research, 11 (2), 59-65.
7. Tosheva Kh., Xalilova F., Gadaev A, Erkinova N., Djuraeva N. Impact Of Chronic Heart Failure On Comorbidities In Hot Climates On The Quality Of Life And Clinical Condition Of Patients. European Journal of Molecular & Clinical Medicine. ISSN 2515-8260 Volume 07, Issue 10, 2020.
8. Khalilova F. et al. COMORBIDE CASES IN CARDIORENAL SYNDROME AND ITS IMPACT ON PATIENTS'QUALITY OF LIFE //InterConf. – 2020.
9. Khalilova F. A. et al. COMORBIDE CASES IN CARDIORENAL SYNDROME AND ITS IMPACT ON PATIENTS'QUALITY OF LIFE //EDITOR COORDINATOR. – 2020. – С. 741.
10. Aslonova I. J. et al. The prevalence of chronic pyelonephritis in women with disturbed tolerance for glucose //Asian Journal of Multidimensional Research (AJMR). – 2019. – Т. 8. – №. 11. – С. 81-85.
11. Aslonova I. Z., Erkinova N. E., Tosheva K. B. The prevalence of chronic pyelonephritis in women with disturbed tolerance for glucose //International Journal of Pharmaceutical Research. – 2019. – Т. 11. – №. 4. – С. 866-868.
12. Тошева Х., Кайимова Д. И. Метаболик синдромнинг ривожланишида ирсиятнинг ахамияти //Биология и интегративная медицина. – 2017. – Т. 1. – С. 132.
13. Клычева М. А. и др. Роль психологии семейного воспитания в формировании поведенческих реакций у подростков //Наука молодых–Eruditio Juvenium. – 2015. – №. 2. – С. 75-79.
14. Bekmurodovna T. K., Chorievich Z. A. Study of frequency indicators of comorbid states at different functional classes of heart failure //ACADEMICIA: An International Multidisciplinary Research Journal. – 2021. – Т. 11. – №. 3. – С. 2556-2560.
15. Bekmurodovna T. K. et al. Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study) //Journal of Cardiovascular Disease Research. – 2020. – Т. 11. – №. 2. – С. 59-65.
16. Bekmurodovna T. K., Gadaevich G. A. Dynamics of Renal Fibrosis Markers on the Basis of Complex Treatment in Chronic Heart Failure with Anemia. – 2021.
17. Khaidarovich K. U., Bekmurodovna T. H., Abduzhalilovna K. F. Studying The Frequency Of The Symptoms Of Gastroesophageal Reflux Disease //JournalNX. – С. 48-52.
18. Тошева Х. Б., Кенжаева З. О. Пропаганда здорового образа жизни в селе как механизм сохранения здоровья сельского населения. – 2014.
19. Тошева Х., Кайимова Д. И. Role of heritable factors in development of the metabolic syndrome //Биология и интегративная медицина. – 2017. – №. 1. – С. 132-146.
20. Гадаев А. Г. и др. Роль некоторых маркеров в оценке течения Хронического кардиоренального синдрома. – 2018.
21. Нурбаев Ф. Э., Тошева Х. Б. Скрининг Сердечно-Сосудистых Заболеваний У Спортсменов //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – С. 8-9.
22. Тошева Х., Хазратов У., Нарзиев Ш. РОЛИ ДИСФУНКЦИИ ПОЧЕК В РАЗВИТИИ КОМОРБИДНОСТИ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ //Журнал вестник врача. – 2020. – Т. 1. – №. 3. – С. 93-96.
23. Khotamova R. S. Frequency of Comorbid Conditions in Chronic Heart Failure //Middle European Scientific Bulletin. – 2022. – Т. 24. – С. 260-264.
24. Khotamova R.S. The Role of Folk Medicine in the Treatment of Patients with Cardiovascular Diseases // Central Asian Journal of Medical and Natural Science (ISSN:2660-4159) Oct. 14, 2021. Page: 280-283.
25. Marenzi G., Lauri G., Guazzi M. et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis // Am J Med Sci. 2001. Vol. 321 (6). P. 359–366.
26. Nohria A., Hasselblad V., Stebbins A. etal.Cardiorenal interactions: insights from the ESCAPE trial // J Am Coll Cardiol. 2008. Vol. 51 (13). P. 1268–1274.
27. Prkacin I., Ozvald I., Cavrić G., Balenović D.,Bulum T., Flegar Mestrić Z. Importance of urinary NGAL, serum creatinine standardization and estimated glomerular filtration rate in resistant hypertension // Coll. Antropol. – 2013. – Vol. 37, №3. – Р. 7821–7825.
28. Ronco C., Haapio M., House A.A. et al. Cardiorenal syndrome // J Am Coll Cardiol. 2008Vol. 52 (19). P. 1527–1539.
29. Ruilope L.M., Segura J., Campo C., Rodicio J.L. Renal participation in cardiovascular risk in essential hypertension // Expert Rev Cardiovasc. Ther. 2003. Vol. 1 (2). P. 309–315.
30. Ronco C. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong / C. Ronco, A.A. House, M. Haapio // Intensive Care Med. – 2008. – Vol. 34. – P. 957–962.
31. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) // N Engl J Med. 1988. Vol. 319 (17). P. 1127–1134.
32. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure // N Engl J Med. 1999. Vol. 341 (8). P. 577–585.
33. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) // N Engl J Med. 1988. Vol. 319 (16). P. 1065–1072.
34. Silverberg D.S., Wexler D., Blum M. et al. The interaction between heart failure, renal failure and anemia – the cardio-renal anemia syndrome // Blood Purif. 2004. Vol. 22 (3). P. 277–284.
35. Waring W.S., Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of chronic kidney injury // Clin. Toxicol. – 2011
36. Yamamoto T., Noble N.A., Cohen A.H. et al.Expression of transforming growth factor β isoforms in human glomerular diseases // Kidney Int. – 1996. – Vol. 49. – Р. 461–469.
Published
2022-08-01
How to Cite
Khotamova, R. S. (2022). Monitoring of Kidney Fibrosis Changes in Patients with Chronic Heart Failure. Central Asian Journal of Medical and Natural Science, 3(4), 199-204. https://doi.org/10.17605/cajmns.v3i4.999
Issue
Section
Articles
